India preparing to become hub for medical technology: Pharmaceuticals Secretary
Government policies and competitive industry driving India’s MedTech sector for sustained double-digit growth
Government policies and competitive industry driving India’s MedTech sector for sustained double-digit growth
The sudden subsequent decision to suspend IXCHIQ is based on updated VAERS data
As with any medicine, the MHRA will keep the safety of gepotidacin under close review
WIDAPLIK is the first and only FDA-approved triple combination medication for use as an initial therapy in patients likely to need multiple drugs to achieve blood pressure goals
The ‘265 Patent is based on Enanta’s July 2020 patent application describing coronavirus protease inhibitors invented by Enanta scientists
Mangalam Drugs and Organics receives repeat export order worth $ 21, 81,040
All 2025 pre-filled syringe doses to be made in Canada, marking a domestic production milestone
Subscribe To Our Newsletter & Stay Updated